Consulting and Registration Services

We offer Registration Services for CDSCO, ICMR, DSIR, BIS, AYUSH, FSSAI, NPPA, CIB & RC, NBAIM for Drugs & Cosmetics, Medical Device, In Vitro Diagnostics, Narcotics, Agrochemicals and Biopesticides.

We also offer wide range of services like Regulatory Support, Toxicology, Preclinical & Clinical DMPK, Biology – Efficacy Studies in Animal Models, Medicinal Chemistry, Synthetic Chemistry, Drug Discovery, Drug Development, Metabolite Studies, E-Fate Studies, Agrochemical Discovery & Development and many more.

Why We Offer Preclinical Research Services for OECD GLP and REACH Studies

With over 13 Years in this industry and our relations with various preclinical contract research organisations (CRO’s) enable you to choose the righteous offerings where services encompass a comprehensive range of range of in vivo non-GLP and GLP safety assessment solutions in both rodent and non-rodent species to thoroughly evaluate pharmaceuticals, biologics, animal health products, agrochemicals, and biocides.

How We Support

We encourage early interaction as a means to develop a regulatory strategy that is appropriate for the complexity of your project and provide guidance and support to your research teams developing and executing preclinical studies.

Solutions

Our solutions include Scientific, Regulatory and Strategic Guidance, Protocol Development, Project Management, IND-enabling and NDA-enabling toxicology, safety pharmacology, and laboratory services that meet global regulatory requirements, for both small and large molecules.

REACH Studies for INDUSTRIAL CHEMICALS

Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH Studies) is a regulatory requirement of European Chemical Agency (ECHA). We have experience and expertise in designing the REACH studies as per European Chemical Agency (ECHA) requirements and submission of the data in the International Uniform Chemical Information Database (IUCLID) format.

Annex VII (1 Tonne or More)

  • Bacterial Reverse Mutation Test (Ames Test) (OECD 471)
  • Acute Oral Toxicity Study in Rats (OECD 420/423/425)
  • Acute Dermal Irritation/Corrosion Study in Rabbits (OECD 404)
  • Acute Eye Irritation/Corrosion Study in Rabbits (OECD 405)
  • Skin Sensitization Study in Guinea Pigs (OECD 406) or
  • Local Lymph Node Assay (LLNA) in CBA/Ca mice (OECD 429)

Annex VIII (10 Tonnes or More)

  • Bacterial Reverse Mutation Test (Ames Test) (OECD 471)
  • In Vitro Mammalian Chromosomal Aberration Test (CHO cells) (OECD 473)
  • In Vitro Mammalian Cell Gene Mutation Test Using the HPRT and XPRT genes (OECD 476)
  • In Vitro Mammalian Cell Micronucleus Test (Human Peripheral Blood Lymphocytes-HPBL) (OECD 487)
  • Acute Oral Toxicity Study in Rats (OECD 420/423/425)
  • Acute Dermal Toxicity Study in Rats (OECD 402)
  • Acute Inhalation Study in Rats (OECD 403)
  • Acute Dermal Irritation/Corrosion Study in Rabbits (OECD 404)
  • Acute Eye Irritation/Corrosion Study in Rabbits (OECD 405)
  • Skin Sensitization Study in Guinea Pigs (OECD 406) or
  • Local Lymph Node Assay (LLNA) in CBA/Ca mice (OECD 429)
  • 28 Day Repeated Dose (OECD 407)
  • Reproductive Toxicity (OECD 421)
  • Developmental Toxicity study (OECD 414)

Annex IX (100 Tonnes Or More)

  • Bacterial Reverse Mutation Test (Ames Test) (OECD 471)
  • In Vitro Mammalian Chromosomal Aberration Test (CHO cells) (OECD 473)
  • In Vitro Mammalian Cell Gene Mutation Test Using the Hprt and xprt genes (OECD 476)
  • In Vitro Mammalian Cell Micronucleus Test (Human Peripheral Blood Lymphocytes-HPBL) (OECD 487)
  • Mammalian Erythrocyte Micronucleus Test (OECD 474)
  • Mammalian Bone Marrow Chromosomal Aberration Test (OECD 475)
  • Acute Oral Toxicity Study in Rats (OECD 420/423/425)
  • Acute Dermal Toxicity Study in Rats (OECD 402)
  • Acute Inhalation Study in Rats (OECD 403)
  • Acute Dermal Irritation/Corrosion Study in Rabbits (OECD 404)
  • Acute Eye Irritation/Corrosion Study in Rabbits (OECD 405)
  • Skin Sensitization Study in Guinea Pigs (OECD 406)
  • Local Lymph Node Assay (LLNA) in CBA/Ca mice (OECD 429) or
  • 90 Day Repeated Dose (OECD 408)
  • Reproductive Toxicity (OECD 421)
  • Developmental Toxicity Study-Rats (OECD 414)
  • Extended One-Generation Reproduction Toxicity Study in Rats (OECD 443)

Annex X (1000 Tonnes or More)

  • Bacterial Reverse Mutation Test (Ames Test) (OECD 471)
  • In Vitro Mammalian Chromosomal Aberration Test (CHO cells) (OECD 473)
  • In Vitro Mammalian Cell Gene Mutation Test Using the Hprt and xprt genes (OECD 476)
  • In Vitro Mammalian Cell Micronucleus Test (Human Peripheral Blood Lymphocytes-HPBL) (OECD 487)
  • Mammalian Erythrocyte Micronucleus Test (OECD 474)
  • Mammalian Bone Marrow Chromosomal Aberration Test (OECD 475)
  • Acute Oral Toxicity Study in Rats (OECD 420/423/425)
  • Acute Dermal Toxicity Study in Rats (OECD 402)
  • Acute Inhalation Study in Rats (OECD 403)
  • Acute Dermal Irritation/Corrosion Study in Rabbits (OECD 404)
  • Acute Eye Irritation/Corrosion Study in Rabbits (OECD 405)
  • Skin Sensitization Study in Guinea Pigs (OECD 406) or
  • Local Lymph Node Assay (LLNA) in CBA/Ca mice (OECD 429)
  • 90 Day Repeated Dose (OECD 408)
  • Reproductive Toxicity (OECD 421)
  • Developmental Toxicity Study-Rats & Rabbits (OECD 414)
  • Extended One-Generation Reproduction Toxicity Study in Rats (OECD 443)
  • Chronic Toxicity (OECD 452)/ Carcinogenicity (Oncogenicity) (OECD 451)

GLP Studies for AGROCHEMICALS

  • Physical Chemical Property Testing
  • Residue, Environment Fate and Behavior Studies
  • 5 Batch Analysis

Genetic Toxicology Studies

  • Bacterial Reverse Mutation Test (Ames Test) (OECD 471)
  • In Vitro Mammalian Chromosomal Aberration Test (CHO cells) (OECD 473)
  • In Vitro Mammalian Chromosomal Aberration Test (Human Peripheral Blood Lymphocytes-HPBL) (OECD 473)
  • In Vitro Mammalian Cell Gene Mutation Test Using the HPRT and XPRT genes (OECD 476)
  • In Vitro Mammalian Cell Micronucleus Test (Human Peripheral Blood Lymphocytes-HPBL) (OECD 487)
  • In Vitro Mammalian Cell Gene Mutation Test Using the Thymidine Kinase Gene (OECD 490)
  • Mammalian Erythrocyte Micronucleus Test (OECD 474)
  • Mammalian Bone Marrow Chromosomal Aberration Test (OECD 475)

In Vitro Studies

  • EpiSkin-In Vitro Skin Corrosion (OECD 431)
  • EpiSkin-In Vitro Skin Irritation (OECD 439)
  • In Vitro Eye Irritation [Bovine Corneal Opacity and Permeability (BCOP) Test] (OECD 437)
  • In Vitro Eye Irritation EpiOcular (OECD 492)
  • In Vitro Skin Sensitization [Dermal Peptide Reactivity Assay (DPRA)] (OECD 442C)
  • In Vitro Skin Sensitization- ARE-Nrf2 Luciferase Test Method [KeratinoSens] (OECD 442D)
  • In Vitro Skin Sensitization [Human Cell Line (U937-U-SENS) Activation Test (h-CLAT)] (OECD 442E)
  • In Vitro Skin Absorption: Franz Cell Diffusion Assay (OECD 428)
  • In vitro Cytotoxicity in Balb/c 3T3 LD50 (OECD 129)

Acute Studies

  • Acute Oral Toxicity Study in Rats (OECD 420/423/425)
  • Acute Dermal Toxicity Study in Rats (OECD 402)
  • Acute Inhalation Study in Rats (OECD 403)
  • Acute Dermal Irritation/Corrosion Study in Rabbits (OECD 404)
  • Acute Eye Irritation/Corrosion Study in Rabbits (OECD 405)
  • Skin Sensitization Study in Guinea Pigs (OECD 406)
  • Local Lymph Node Assay (LLNA) in CBA/Ca mice (OECD 429)

Repeated Dose

  • Dose range finding (7 to 14 day) toxicology studies in Mice/Rats
  • Dose range finding (7 to 14 day) toxicology studies in Beagle Dogs
  • 28-day repeat dose toxicity studies in Mice/Rats
  • 28-day repeat dose toxicity studies in Beagle Dogs
  • 90-day repeat dose toxicity studies in Mice/Rats
  • 90-day repeat dose toxicity studies in Beagle Dogs
  • 21/28-day repeat dose dermal toxicity studies in Rats/Rabbits
  • 90-day repeat dose dermal toxicity studies in Rats/Rabbits
  • 28-day Inhalation toxicity studies in Rats
  • 90-day Inhalation toxicity studies in Rats

Developmental & Reproductive Toxicology Studies

  • Prenatal Developmental Toxicity Study in Mice/rats/Rabbits (OECD 414)
  • One Generation Reproductive Toxicity Study in Mice/Rats (OECD 415)
  • Two Generation Reproductive Toxicity Study in Mice/Rats (OECD 416)
  • Reproduction/Developmental Toxicity Screening Test in Rats (OECD 421)
  • Combined Repeated Dose with Reproduction/Developmental Toxicity Screening Test in Rats (OECD 422)
  • Extended One-Generation Reproduction Toxicity Study in Rats (OECD 443)

Endocrine Disruption Studies

  • Uterotrophic Bioassay in Rats (OECD 440)
  • Hershberger Bioassay in Rats (OECD 441)

Neurotoxicity Studies

  • Delayed Neurotoxicity of Organophosphorus substances following acute exposure (OECD 418)
  • Delayed Neurotoxicity of Organophosphorus substances 28-day repeated dose study (OECD 419)
  • Neurotoxicity Study in Rats (OECD 424)
  • Developmental Neurotoxicity Study in Rats (OECD 426)

Chronic / Carcinogenicity / Oncogenicity Studies

  • Carcinogenicity study in Mice/Rats (OECD 451)
  • Chronic Toxicity studies in Mice/Rats (OECD 452)
  • Combined Chronic Toxicity/Carcinogenicity study in Mice/Rats (OECD 453)

Metabolism Studies-Using 14C labeled compounds

  • Toxicokinetics / Mass balance study in rats (OECD 417)
  • Skin absorption study in rats (OECD 427)
  • Metabolism in Livestock -Goat, Chicken and Swine (OECD 503)
  • Residues in Livestock -Goat, Chicken and Swine (OECD 505)

Ecotoxicology (Ecotox) studies

  • Acute toxicity test in fish
  • Acute toxicity test in daphnia
  • Acute toxicity test in alga
  • Acute toxicity test in earthworm
  • Acute toxicity test in honey bee (oral & contact)
  • Ready biodegradability study (carbon dioxide evolution test)
  • Acute Oral Toxicity Study in birds [Japanese Quails/Chicken/Pigeon] (OECD 223)
  • Avian Dietary Toxicity Study in Japanese Quails (OECD 205)
  • Reproductive Toxicity in Birds-Japanese Quails (OECD 206)

Cosmetics Product Testing and Studies

Cosmetics and consumer product testing is required to assess the toxicity and quality to responsibly, safely, and efficiently market this product without an unreasonable risk of injury to the consumer.

We offer following services:

In vitro Studies

  • Episkin-In Vitro Skin Corrosion (OECD 431)
  • Episkin-In Vitro Skin Irritation (OECD 439)
  • In Vitro Eye Irritation [Bovine Corneal Opacity and Permeability (BCOP) Test] (OECD 437)
  • In Vitro Eye Irritation EpiOcular (OECD 492)
  • In Vitro Skin Sensitization [Dermal Peptide Reactivity Assay (DPRA)](OECD 442C)
  • In Vitro Skin Sensitization- ARE-Nrf2 Luciferase Test Method [KeratinoSens] (OECD 442D)
  • In Vitro Skin Sensitization [Human Cell Line (U937-U-SENS) Activation Test (h-CLAT)] (OECD 442E)
  • In Vitro Skin Absorption: Franz Cell Diffusion Assay (OECD 428)
  • In Vitro cytotoxicity in Balb/c 3T3 LD50 (OECD 129)

Drug Discovery & Development

Drug Discovery & Development

  • Conceptualise, and evaluate drug targets
  • Assay development
  • High-throughput screening (HTS)
  • Hit identification and hit-to-lead to lead-optimisation
  • PK-PD
  • Identification of Biomarker
  • Mechanism of action
  • Combination Studies
  • DMPK
  • Non-GLP and GLP Toxicology
  • IND filing
 
 

Preclinical Toxicology

  • Designing, Implementation and Management of Preclinical Testing Programs
  • Nonclinical overviews, interpretation, and positioning of data (toxicology study reports, literature, safety data)
  • Toxicological Risk Assessments for Impurities, Leachable & Extractable
  • Determination of Permitted Daily Exposure (PDE) and Occupational Exposure Limits
  • Environmental Risk Assessments
  • Gap analysis and independent data reviews
  • GLP study monitoring, including pre-placement and in-life study audits

Medicinal Chemistry

  • Rational Drug Design
  • IP Generation
  • Multi-Dimensional Optimisation (MDO)
  • X-ray crystallography

ADME

  • Absorption, Distribution, Metabolism, and Excretion related issues of the compounds translating preclinical information to clinical trials

Biology

  • Molecular Biology, Biochemistry, Cell Biology and in vivo biology
  • Evaluation of drug targets
  • Establishment of screening cascade
  • Mechanism of action
  • Identification of biomarkers
  • Combination studies
  • Efficient experimental design and data collection to qualify leads and clinical candidates

Synthetic Chemistry

  • Solutions for synthetic routes
  • Custom synthesis

Laboratory Infrastructure Setup

  • Integrated drug discovery and development centre including biology, chemistry, DMPK, Toxicology and translational labs
  • Animal house with AAALAC accreditations
  • OECD GLP Toxicology facility Setup as per OECD Guidelines
  • Biosafety Level 3 (BSL-3) Laboratory Setup
  • Design & Setup of Radiotracer Lab and Cyclotron Project

REVO - Comprehensive Toxicity Prediction Platform

REVO is a comprehensive toxicity prediction platform which provides multiple levels of toxicity alerts in compliance with the requirements of regulatory authorities for product approval.

It has robust and tested methodologies derived from the collective expertise of field toxicologists, scientific and data inputs from reputed research institutes. REVO is well accepted by the industry.

REVO provides alerts for genotoxicity along with probability values which indicate the significance of toxicophores.

The unique Three Pronged Approach of REVO combines reliable:

  • Decision tree methodology: It employs rule base in accordance with the results of Joint Research Centre’s European Chemicals Bureau`s hazard estimation based on the Benigni/Bossa rule base for genotoxic carcinogenicity and mutagenicity (Benigni et .al. JRC Scientific and Technical, 2008).
  • ANOVA methodology: It provides the significance of the toxicophores of carcinogenicity based on F-ratio and probability
  • SAR / QSAR models: The models provide qualitative prediction for mutagenicity and carcinogenicity along with confidence level of prediction based on applicability domain

Additionally REVO provides molecular fingerprint based similarity search in database of toxic compounds to increase confidence level of genotoxicity prediction.

REVO databases include:

  • Compounds having TD50 values reported for rats and mouse species from Handbook of Carcinogenic Potency and Genotoxicity Database of Gold and Zieger.
  • Ames dataset for Mutagenicity, CPDB dataset for mutagenicity and carcinogenicity and dataset for COMET assay.
  • REVO allows use of customers databases for its predictions where available.

 

REVO uses both Expert Rule based as well as Statistics based evaluation for genotoxic mutagenicity and carcinogenicity in accordance with ICH M7 guidelines. The QSTR models used in REVO are validated as per REACH guidelines as recommended by OECD Guidance.

Our reports are well accepted by the regulatory bodies (eg. EDQM, EMA, USFDA). 

Agrochemicals Impurities

While generating the product specifications for global regulatory submissions, 5 Batch Analysis is essential for the registration of agrochemicals that is required to prove their chemical uniformity.

For Global Regulatory Submissions, Impurity Profiling is MUST and this is where we support you with our expertise, we perform impurity profiling of technical grade pesticides with complete profiling of the molecule including identifying and quantifying the impurities both process related and degradation by-products along with the quantification of active ingredient.

The impurities, being present usually in the range from a few percent to 0.1%, but in special cases at or below 0.01 mg/kg must be determined. The analysis and identification of the impurities may require the combined application of several instrumental analytical techniques such as GC-MS, LC-MS, GC-FTIR and high resolution NMR, In GC or HPLC quantitative analysis to separate the active ingredient from the impurities is of vital importance.

We analyse all types of molecules as per the international guidelines such as OECD, CIPAC, BIS, OPPTS, EPA, EU, ASTM, EEC, FDA, IP, USP, ICH, ABNT NBR, SANCO and WHO.

Regulatory Consultancy Services

Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH Studies) is a regulatory requirement of European Chemical Agency (ECHA). We have experience and expertise in designing the REACH studies as per European Chemical Agency (ECHA) requirements and submission of the data in the International Uniform Chemical Information Database (IUCLID) format.

DRUGS

  • Assists in Import Registration, New Drugs, Subsequent New Drugs,Clinical trials, Dual Use NOC, Test License, Registration & Renewals.

COSMETICS


  • Providing most efficient and comprehensive Regulatory solutions for Registrations of Cosmetics, Renewals, Amendments, Label Reviews

IN VITRO DIAGNOSTICS

  • Suggest Regulatory Direction in the all new MDR Rules. Guidance on Notified and Non Notified Devices, Registrations,Test Licenses and More

MEDICAL DEVICES

  • Provides Tailor Made Regulatory Solutions & Services in the midst of new MDR Rules & Regulations.

INDIAN AGENT REPRESENTATION

  • Offers Bespoke & On-demand Registration holding Services to Global Companies.

NARCOTICS

  • We provides Clear Regulatory pathway Under the Narcotic Drugs and Psychotropic Substances Act, 1985 Regulated by Central Bureau of Narcotics.

NIB NOIDA

  • Offers On-demand Testing Support Services at National Institute of Biologicals,Noida.

CDL KASAULI

  • Offers On-demand Testing Support Services at Central Drugs Laboratory, Kasauli.

VACCINES & BIOLOGICALS

  • We provide Consulting services for Registration and Import Licenses for Vaccines & Biologicals.

DSIR

  • Provides Consulting Services for Recognition under Department of Scientific & Industrial research to Help companies apply for Tax Benefits by having In house recognitions.

NPPA

  • Provides Consulting Services under drug prices control order 1995 – National Pharmaceutical Pricing Authority.

BUREAU OF INDIAN STANDARDS

  • We offers Product Certification Services for Products Covered under ISI & CRS Schemes under Bureau of Indian Standards.

VETERINARY

  • We offer end to end Service for Launching a New Veterinary product in Indifrom CDSCO

FSSAI(FOOD)

  • Offers Quick Submission & Approval under Wireless Planning & Coordination and ETA Approvals

AYUSH

  • We offer Guidance on approval for COPP(Certificate of Pharmaceutical Products) for AYUSH products

NBAIM CULTURE COLLECTION (NAIMCC)

  • Provides Consulting Services for General Deposit of Microorganisms, Safe Deposit of Microorganisms, Registration of Elite Microbes, Patent Deposits of Microorganisms, Supply of Microbial Cultures

CENTRAL INSECTICIDE BOARD(CIB)

  • Provides Consulting Services for Registration of various Pesticides, Insecticides, Fungicides, Herbicides, Household insecticides, Bio Pesticides, Bio-fertilizers and PGR U/s 9(3B), 9(3) & 9(4) of the Insecticides Act, 1968, Govt. of India., Registration under Section 9(4) Formulation, Registration under section 9(4) TIM, Export of Existing / New Technical/Formulations, Registration under Section 9(3)B, Enhancement of Product Shelf Life, Packing, RTT Permit, Endorsement for transfer of cir/Shifting the address/Company name change, Inclusion of products in schedule of Insecticides Act, 1968

AERB (Atomic Energy Regulatory Board) Approvals

  • Our expertise in the area of radioisotope is Radio labelling in general, Design of the radio tracer experiments, Radio iodination, Training in Radioactivity Handling, AERB (Atomic Energy Regulatory Board) Approval Process for use of radio tracer and for establishing Radiotracer Laboratory, Radio-pharmaceuticals,

    Radioimmunoassay, Guidance and identifying radioisotope and labeled compound sourcing, Radio Safety Officer (RSO) Training, RSO Consultants

Need Advice?

Call Us for Registration Services for CDSCO, ICMR, DSIR, BIS, AYUSH, FSSAI, NPPA, CIB & RC, NBAIM for Drugs & Cosmetics, Medical Device, In Vitro Diagnostics, Narcotics, Agrochemicals and Bio-pesticides.

Consulting and Registration Services

Our Services

Regulatory Support & Consultancy Services, GLP Studies for AGROCHEMICALS, REACH Studies for INDUSTRIAL CHEMICALS, Cosmetics Product Testing and Studies, Toxicology, Drug Discovery and Development, Laboratory Infrastructure Setup, REVO – Comprehensive Toxicity Prediction Platform, Agrochemicals Impurities, Carbon 14 Analysis, C-14 & Tritium for E-Fate Studies, Design & Setup of Radiotracer Lab and Cyclotron, ARC Catalogue Products, RadioLabeled Isotopes, Custom Synthesis of Radioactive Materials and UnLabeled Compounds for Agrochemicals & Pesticides, Fertilisers and Life Science Research.

medbotics llp

Our Motto

Our ‘Client First’ motto drives us to prioritise regulatory challenges which allow both flexibility for the client and compliance to be a reference of excellence in the global supply of solutions for validation in order to enable regulatory compliance for companies of all sizes.

Vision

Following the best regulatory practices combining our expertise & experience with client’s insights

Mission

To deliver tangible and sustainable results to the clients by innovative proposals, digital transformation, information security and sustainability.

Medbotics LLP

Scroll to Top